SANDRA BUSHMAN: Open Payments
NPI 1215262969 · DELPHI, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 51 payments from 14 companies in 2025. Trend: 2023 $110 · 2024 $630 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $208 |
| ABBVIE INC. | 16 | $205 |
| Corium, LLC | 7 | $95 |
| Novo Nordisk Inc | 2 | $49 |
| Organon LLC | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $28 |
| PFIZER INC. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: CAPLYTA, VRAYLAR, Azstarys, QULIPTA, NEXPLANON, Ozempic, Xelstrym, NURTEC ODT.
Industry payments across IN — which companies pay providers there.
